Study to Investigate the Potential of Probiotics in Yogurt

PHASE3CompletedINTERVENTIONAL
Enrollment

182

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Healthy
Interventions
DRUG

Bifidobacterium lactis (BB-12)

The active drink is currently available commercially on campus at The Berkey Creamery at Penn State in State College, Pennsylvania. The active drink combined a commercial blend (YFL-702, Chr.) of the following active cultures, Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus. The active drink was also supplemented with the probiotic BB-12, acquired from Chr. Hansen (Milwaukee, Wisconsin).

DRUG

Placebo

The placebo drink combined a commercial blend (YFL-702, Chr.) of the following active cultures, Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus.

Trial Locations (1)

20007

Georgetown University Department of Family Medicine, Washington D.C.

All Listed Sponsors
collaborator

The Gerber Foundation

OTHER

lead

Georgetown University

OTHER

NCT00492583 - Study to Investigate the Potential of Probiotics in Yogurt | Biotech Hunter | Biotech Hunter